Carl Fichtenbaum is an Infectious Disease physician. ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Albert Sabin Way
# 405
Cincinnati, OH 452672800
Telephone
513-584-6977Registry record last updated 27 Mar 2014.
Clinical trials
- CCR5-modified CD4+ T Cells for HIV Infection
Sponsor: University of Cincinnati
- Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection
Sponsor: University of Cincinnati
- Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study
Sponsor: University of Cincinnati
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20258 payments
- ViiV Healthcare CompanyProgram year20252 payments
- Gilead Sciences, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
32.7%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor10.4%Tivicay48%Dovato27%Juluca16%Isentress10%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor6.4%Descovy72%Triumeq28%Part D<11 patients+ 9 more classes in this area
Cardiovascular
19.8%Statin8.7%Atorvastatin Calcium53%Rosuvastatin Calcium35%Pravastatin Sodium12%Part D<11 patientsBeta blocker2.9%Metoprolol Succinate39%Carvedilol29%Metoprolol Tartrate17%Atenolol15%Part D<11 patients+ 9 more classes in this area
Nervous system
19%Opioid Agonist4.2%Oxycodone-Acetaminophen75%Fentanyl12%Tramadol Hcl12%Part D<11 patientsGabapentinoids3.4%Gabapentin80%Pregabalin20%Part D<11 patients+ 11 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 1999–2013 per NIH RePORTER. The latest:
- University of Cincinnati AIDS Clinical Trials Unit- UC ACTU
University of Cincinnati
FY2013$1,560,131UM1AI069513 - University of Cincinnati AIDS Clinical Trials Unit- UC ACTU
University of Cincinnati
FY2012$1,668,393UM1AI069513 - University of Cincinnati AIDS Clinical Trials Unit- UC ACTU
University of Cincinnati
FY2011$1,635,950U01AI069513
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”